NCT00720447View on ClinicalTrials.gov

Donor Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma

PHASE2UnknownINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

November 30, 2010

Conditions
Lymphoma
Interventions
BIOLOGICAL

alemtuzumab

BIOLOGICAL

donor lymphocytes

DRUG

carmustine

DRUG

cytarabine

DRUG

etoposide

DRUG

melphalan

PROCEDURE

allogeneic bone marrow transplantation

PROCEDURE

peripheral blood stem cell transplantation

Sponsors

Lead Sponsor

Cancer Research UK
All Listed Sponsors
lead

Cancer Research UK

OTHER